SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.01
-0.09 (-4.29%)
At close: Sep 26, 2025, 3:59 PM
2.06
2.49%
After-hours: Sep 26, 2025, 06:01 PM EDT
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.96% growth. For the quarter ending June 30, 2025, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
1.32M
Revenue Growth
-40.96%
Price / Sales Ratio
26.55
Revenue / Employee
20.98K
Employees
63
Market Cap
20.93M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.32M | -40.96% |
| Dec 31, 2023 | 2.24M | -90.63% |
| Dec 31, 2022 | 23.9M | -60.73% |
| Dec 31, 2021 | 60.88M | +10.21% |
| Dec 31, 2020 | 55.24M | +1504.82% |
| Dec 31, 2019 | 3.44M | n/a |